Therapeutic Targeting of the General RNA Polymerase II Transcription Machinery.

Inhibitors targeting the general RNA polymerase II (RNAPII) transcription machinery are candidate therapeutics in cancer and other complex diseases. Here, we review the molecular targets and mechanisms of action of these compounds, framing them within the steps of RNAPII transcription. We discuss the effects of transcription inhibitors in vitro and in cellular models (with an emphasis on cancer), as well as their efficacy in preclinical and clinical studies. We also discuss the rationale for inhibiting broadly acting transcriptional regulators or RNAPII itself in complex diseases.

Citation

Ryan D Martin, Terence E Hébert, Jason C Tanny. Therapeutic Targeting of the General RNA Polymerase II Transcription Machinery. International journal of molecular sciences. 2020 May 09;21(9)

Mesh Tags

Substances

PMID: 32397434

search → result